An overview of cephalosporin antibiotics as emerging contaminants: a serious environmental concern
- PMID: 31139546
- PMCID: PMC6534636
- DOI: 10.1007/s13205-019-1766-9
An overview of cephalosporin antibiotics as emerging contaminants: a serious environmental concern
Abstract
Antibiotics have been categorized as emerging pollutants due to their indiscriminate usage, continuous input and persistence in various environmental matrices even at lower concentrations. Cephalosporins are the broad-spectrum antibiotics of β-lactam family. Owing to its enormous production and consumption, it is reported as the second most prescribed antibiotic classes in Europe. The cephalosporin wastewater contains toxic organic compounds, inorganic salts, and active pharmaceutical ingredients (API) which pose a potential threat to the organisms in the environment. Therefore, removal of cephalosporin antibiotics from the environment has become mandatory as it contributes to increase in the level of chemical oxygen demand (COD), causing toxicity of the effluent and production of cephalosporin-resistant microbes. So far, several processes have been reported for degradation/removal of cephalosporins from the environment. A number of individual studies have been published within the last decade covering the various aspects of antibiotics. However, a detailed compilation on cephalosporin antibiotics as an emerging environmental contaminant is still lacking. Hence, the present review intends to highlight the current ecological scenario with respect to distribution, toxicity, degradation, various remediation technologies, and the regulatory aspects concerning cephalosporins. The latest successful technologies for cephalosporin degradation/removal discussed in this review will help researchers for a better understanding of the nature and persistence of cephalosporins in the environment along with the risks associated with their existence. The research thrust discussed in this review will also evoke new technologies to be attempted by the future researchers to develop sustainable options to remediate cephalosporin-contaminated environments.
Keywords: Cephalosporin; Environment; Pharmaceuticals; Wastewater; β-lactam antibiotics.
Conflict of interest statement
Conflict of interestThe authors declare that they have no conflict of interest.
Figures
References
-
- Abraham S, Jordan D, Wonga HS, Johnson JR, Toleman MA, Wakeham DL, Gordon DM, Turnidge JD, Mollinger JL, Gibson JS, Trott DJ. First detection of extended-spectrum cephalosporin- and fluoroquinolone-resistant Escherichia coli in Australian food-producing animals. J Glob Antimicrob Resist. 2015;3:273–277. - PubMed
-
- Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H. European surveillance of antimicrobial consumption (ESAC): outpatient antibiotic use in Europe (1997–2009) J Antimicrob Chemother. 2012;66:3–12. - PubMed
-
- Ahmed MB, Zhou JL, Ngo HH, Guo W. Adsorptive removal of antibiotics from water and wastewater: progress and challenges. Sci Total Environ. 2015;532:112–126. - PubMed
-
- Alexy R, Kümpel T, Kümmerer K. Assessment of degradation of 18 antibiotics in the closed bottle test. Chemosphere. 2004;57:505–512. - PubMed
-
- Al-Maadheed S, Ipek G, Aishah BA, Latiff BS. Antibiotics in hospital effluent and domestic wastewater treatment plants in Doha, Qatar. J Water Process Eng. 2019;28:60–68.
Publication types
LinkOut - more resources
Full Text Sources
